Senti Biosciences is trading at $0.38, up +6.49%, alongside broader market strength.

  • The Nasdaq Composite is up 0.72%, with investors focused on the July CPI report.
  • Searches found no new company-specific announcement dated August 12, 2026.
  • The latest major company news remains the May 14 FDA RMAT update, making broader market sentiment the most likely explanation.